Oculodermal melanocytosis.

Indian J Med Res

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi 110 029, India.

Published: June 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602935PMC
http://dx.doi.org/10.4103/ijmr.IJMR_1950_17DOI Listing

Publication Analysis

Top Keywords

oculodermal melanocytosis
4
oculodermal
1

Similar Publications

[Choroidal melanoma with nevus of Ota].

J Fr Ophtalmol

January 2025

Service d'ophtalmologie, hôpital Claude-Huriez, CHU de Lille, rue Michel-Polonowski, Lille, France.

View Article and Find Full Text PDF

Background: The effectiveness and safety of 730-nm picosecond laser for treating acquired bilateral nevus of Ota-like macules remain uncertain.

Objective: This study aims to evaluate the potential benefits and risks of using the 730-nm picosecond laser for ABNOM removal.

Methods: This is a retrospective review of patients who were presented to the clinic between January 2020 and January 2024 for the treatment of ABNOM with 730-nm picosecond laser alone.

View Article and Find Full Text PDF

Background: Nevus of Hori (HN) has been primarily reported in patients of Eastern Asian descent, with a paucity of data regarding HN occurring in African patients. In this study, we report on South African patients with HN initially thought to have melasma.

Objective: To characterize the histopathological and clinical phenotypes of HN in African patients.

View Article and Find Full Text PDF

Objective: To study the prevalence, clinical presentation, treatment, and follow-up of ocular (dermal) melanocytosis (ODM) and its association with choroidal melanoma (CM) in Asian Indian patients.

Methods: This was a retrospective case series of patients with ODM conducted in a quaternary eye care center.

Results: Of the total 1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!